Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HRS-7535 in diabetic kidney disease with type 2 diabetes
NCT06415214Phase 2Completed
- Sponsor
- Shandong Suncadia Medicine Co., Ltd.
- Start
- Jun 2024
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of HRS-7535 in diabetic kidney disease (DKD), sponsored by Shandong Suncadia Medicine Co., Ltd.. Started Jun 2024; status: completed.
02
Drugs
HRS-7535
03
Conditions
diabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT06415214.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06415214.